Schedel I, Beck P, Peest D, Schneider K D, Fricke M, Eckert G, Deicher H
Adv Exp Med Biol. 1979;114:833-9. doi: 10.1007/978-1-4615-9101-6_137.
Antisera raised against idiotypic determinants of myeloma proteins and macroglobulins have been used to differentiate peripheral blood lymphocytes populations from individual patients. I.D.-positive lymphocytes not resembling plasma cells have been regularly found in peripheral blood in these diseases. This lymphocyte population is heterogeneous with respect to non-tumor-specific surface markers, such as SRBC-, Fc- and C-receptors. Tumor specific idiotypic determinants will thus allow a more correct recognition of the total tumor cell compartment in these diseases.
针对骨髓瘤蛋白和巨球蛋白独特型决定簇产生的抗血清已被用于区分个体患者外周血淋巴细胞群体。在这些疾病的外周血中经常发现不类似于浆细胞的ID阳性淋巴细胞。就非肿瘤特异性表面标志物而言,如绵羊红细胞、Fc和C受体,该淋巴细胞群体是异质性的。因此,肿瘤特异性独特型决定簇将更正确地识别这些疾病中的全部肿瘤细胞区室。